How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study

被引:0
作者
Jacopo Sgrignani
JingJing Chen
Andrea Alimonti
Andrea Cavalli
机构
[1] Università della Svizzera Italiana (USI),Institute for Research in Biomedicine (IRB)
[2] Swiss Institute of Bioinformatics,Institute of Research in Oncology (IOR)
[3] Università della Svizzera Italiana (USI),undefined
来源
Scientific Reports | / 8卷
关键词
Catalytic Site Structure; Specific Cancer Cell Lines; Thiamine Diphosphate (ThDP); Molecular Hydrophobicity Potential (MHP); Thiamine Pyrophosphate;
D O I
暂无
中图分类号
学科分类号
摘要
Pyruvate (PYR) dehydrogenase complex (PDC) is an enzymatic system that plays a crucial role in cellular metabolism as it controls the entry of carbon into the Krebs cycle. From a structural point of view, PDC is formed by three different subunits (E1, E2 and E3) capable of catalyzing the three reaction steps necessary for the full conversion of pyruvate to acetyl-CoA. Recent investigations pointed out the crucial role of this enzyme in the replication and survival of specific cancer cell lines, renewing the interest of the scientific community. Here, we report the results of our molecular dynamics studies on the mechanism by which posttranslational modifications, in particular the phosphorylation of three serine residues (Ser-264-α, Ser-271-α, and Ser-203-α), influence the enzymatic function of the protein. Our results support the hypothesis that the phosphorylation of Ser-264-α and Ser-271-α leads to (1) a perturbation of the catalytic site structure and dynamics and, especially in the case of Ser-264-α, to (2) a reduction in the affinity of E1 for the substrate. Additionally, an analysis of the channels connecting the external environment with the catalytic site indicates that the inhibitory effect should not be due to the occlusion of the access/egress pathways to/from the active site.
引用
收藏
相关论文
共 169 条
  • [1] Patel MS(2014)The pyruvate dehydrogenase complexes: structure-based function and regulation J Biol Chem 289 16615-16623
  • [2] Nemeria NS(2011)Oxidative phosphorylation in cancer cells Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807 534-542
  • [3] Furey W(2015)Stem cells, mitochondria and aging Biochimica et Biophysica Acta (BBA) - Bioenergetics 1847 1380-1386
  • [4] Jordan F(2017)Design and optimization of N-acylhydrazone pyrimidine derivatives as E. coli PDHc E1 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study Bioorg. Med. Chem. 25 5652--6502
  • [5] Solaini G(2017)Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1 Inhibitors against Cyanobacteria Biochemistry 56 6491-817
  • [6] Sgarbi G(2016)The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents Int. J. Cancer 138 809-228
  • [7] Baracca A(2018)Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer Nat. Genet. 50 219-40052
  • [8] Ahlqvist KJ(2015)Specific inhibition by synthetic analogs of pyruvate reveals that the pyruvate dehydrogenase reaction is essential for metabolism and viability of glioblastoma cells Oncotarget 6 40036-550
  • [9] Suomalainen A(2017)The Pyruvate Dehydrogenase Complex and Related Assemblies in Health and Disease Subcell. Biochem. 83 523-37229
  • [10] Hämäläinen RH(2001)Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase J. Biol. Chem. 276 37223-77